17.79BMarket Cap
21.75P/E TTM
Institutional Confidence
Currency: USD Updated: 2026-07-31The current institutional shareholding score of Genmab A/S is 3.00, ranking 192 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 12.10%, representing a quarter-over-quarter increase of 13.72%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.72% of shares outstanding, with 0.11% increase in holdings.
Institutional Shareholding
Shareholder Activity
Orbis Investment Management Ltd.
Paradigm BioCapital Advisors LP
Arrowstreet Capital, Limited Partnership
BlackRock Institutional Trust Company, N.A.
Parametric Portfolio Associates LLC
First Trust Advisors L.P.
Federated Hermes Global Investment Management Corp.